Trial intelligence / Profile preview

Real-world study of Motherwort injection after abortion or IUD procedures

ChiCTR2000038692Phase 4Recruiting

Sponsor
Henan Provincial People's Hospital
Start
Oct 2020
Countries
1
01

Overview

Phase 4, open-label trial of Motherwort in Post-abortion state, post-intrauterine device removal state and menstrual disorders (2 arms), sponsored by Henan Provincial People's Hospital. Primary endpoints: vaginal bleeding time and menstruation recovery time. Started Oct 2020; status: recruiting.

02

Drugs

Motherwort
03

Conditions

Post-abortion statepost-intrauterine device removal statemenstrual disorders

Beyond the preview

Go deeper on ChiCTR2000038692.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000038692.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call